To test this hypothesis, we adoptively transferred anti-4-1BB Abs into tumor-bearing animals following treatment with the E7 DNA vaccine regimen {E7 DNA vaccines (pE7)+IL-2 cDNA (pIL-2)}. The gene discussed is TNFRSF9; the disease is neoplasm.